LifeStance Health Group CTO Sells Company Stock
1 report, 1 independent
Updated Sep 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Vukasin Paunovich, Chief Technology Officer of LifeStance Health Group, sold 42,067 shares of the company's common stock. The transaction was reported via a recent SEC Form 4 filing regarding sales made on September 2, 2026. The sale was executed at a weighted average price of $12.87 per share.
From fool.com
Why it matters
The sale reduced Paunovich's direct equity holdings to approximately 205,000 shares, representing a market value of $2.6 million as of the September 2, 2026, close. The executive's remaining stake accounted for about 0.05% of the company's total shares outstanding.
From fool.com
Who's involved
Keep exploring
The entities involved
-
SEC
Slovak company
Related events
- Insider Amir Shojaei sold 11,250 shares of Harrow Health, which was disclosed to the SEC.
- PHINIA filed disclosures with the SEC regarding executive stock sales and institutional investor activity.
- A director of Kingsway Financial Services sold shares following company disclosure.
- Pharvaris N.V. filed disclosures with the SEC, and its president sold company stock.
- Rimini Street disclosed a stock sale in a legal filing with the Securities and Exchange Commission.